Comparison between Q-Line Biotec IPO and Skytech Infinite Platform IPO.
Q-Line Biotec IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Skytech Infinite Platform IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Q-Line Biotec IPO is up to ₹203.74 Cr whereas the issue size of the Skytech Infinite Platform IPO is up to ₹0.00 Cr. The final issue price of Q-Line Biotec IPO is ₹343.00 per share and of Skytech Infinite Platform IPO is .
| Q-Line Biotec IPO | Skytech Infinite Platform IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹326.00 per share | |
| Issue Price (Upper) | ₹343.00 per share | |
| Issue Price (Final) | ₹343.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 400 shares | |
| Fresh Issue Size | 59,40,000 shares | 29,46,000 shares |
| Fresh Issue Size (Amount) | up to ₹203.74 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 59,40,000 shares | 29,46,000 shares |
| Issue Size Total (Amount) | up to ₹203.74 Cr | up to ₹0.00 Cr |
Q-Line Biotec IPO opens on May 21, 2026, while Skytech Infinite Platform IPO opens on . The closing date of Q-Line Biotec IPO and Skytech Infinite Platform IPO is May 25, 2026, and , respectively.
| Q-Line Biotec IPO | Skytech Infinite Platform IPO | |
|---|---|---|
| Anchor Bid Date | May 20, 2026 | |
| Issue Open | May 21, 2026 | |
| Issue Close | May 25, 2026 | |
| Basis Of Allotment (Tentative) | May 26, 2026 | |
| Initiation of Refunds (Tentative) | May 27, 2026 | |
| Credit of Share (Tentative) | May 27, 2026 | |
| Listing date (Tentative) | May 29, 2026 | |
| Anchor Lockin End date 1 | Jun 25, 2026 | |
| Anchor Lockin End date 2 | Aug 24, 2026 |
Q-Line Biotec IPO P/E ratio is 20.82, as compared to Skytech Infinite Platform IPO P/E ratio of .
| Q-Line Biotec IPO | Skytech Infinite Platform IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.77 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹800.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.66 | 33.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.87 | 0.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹16.47 | ₹5.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.74 | 25.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Q-Line Biotec IPO Retail Individual Investors (RII) are offered 20,79,200 shares while in Skytech Infinite Platform IPO retail investors are offered 20,79,200 shares. Qualified Institutional Buyers (QIB) are offered 11,88,000 shares in Q-Line Biotec IPO and 0 shares in Skytech Infinite Platform IPO.
| Q-Line Biotec IPO | Skytech Infinite Platform IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,81,200 shares | 0 shares |
| Market Maker Reservation | 3,13,200 shares | 0 shares |
| QIB | 11,88,000 shares | 0 shares |
| NII | 8,91,600 shares | 0 shares |
| RII | 20,79,200 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 59,40,000 shares | 0 shares |
Q-Line Biotec IPO subscribed 71.71x in total, whereas Skytech Infinite Platform IPO subscribed .
| Q-Line Biotec IPO | Skytech Infinite Platform IPO | |
|---|---|---|
| QIB (times) | 123.94x | |
| NII (times) | 145.98x | |
| Big NII (times) | 178.29x | |
| Small NII (times) | 81.35x | |
| RII (times) | 71.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 71.71x |
